Review Article

Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction

Author(s): Hayrettin O. Gulcan and Ilkay E. Orhan*

Volume 22, Issue 14, 2021

Published on: 20 January, 2021

Page: [1618 - 1628] Pages: 11

DOI: 10.2174/1389450122666210120144921

Price: $65

Abstract

Flavonoids are chromene analogues abundantly found in plants. It has always been of interest to discover natural flavonoid structures, since living things, including humans, are routinely exposed to these compounds through many dietaries. So far, numerous studies have been conducted on flavonoids with diverse biological actions. The activity results obtained, particularly regarding the effects of flavonoids on various validated and non-validated targets of Alzheimer’s Disease (AD), make these compounds promising agents either to be directly employed in clinical trials or to be utilized as important scaffolds for flavonoid-based drug design studies. Although there are many review articles on the treatment and protective effects of flavonoids on AD, within this review, the effects of flavonoids on mitochondrial dysfunction developing throughout AD have been presented concomitant to their structural organization.

Keywords: Flavonoids, Alzheimer's disease, mitochondrial dysfunction, reactive oxygen species, amyloid beta, chromene analogues.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy